BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas is on the steering committeee of the "Partnering for Global Health Forum 2008" in Washington, DC
News | 03. 10. 2008
